• search
For Quick Alerts
For Daily Alerts

3-D kidney atlas to help researchers, physicians treat renal diseases

By Super Admin

Washington, May 16 (ANI): In a bid to diagnose and treat renal diseases early and more successfully, researchers from nine European countries have spent four-and-a half years to create a three-dimensional virtual "Kidney Atlas", which incorporates the latest research findings on the development and diseases of the kidney.

The Kidney Atlas was part of the European Renal Genome Project (EuReGene), coordinated by the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, which the European Union (EU) funded with more than 10 million euros.

Renal disease not only affects the elderly because of hypertension and diabetes, but also targets children, who are often born with congenital renal anomalies.

Particularly, the increase in the incidence of type 2 diabetes has caused a rise in the number of renal patients.

While the primary aim of the Kidney Atlas is to map genes that play a key role in renal diseases, it also contains other data, for example on anatomy.

The Kidney Atlas, primarily directed towards both basic researchers and clinicians, also contains information for the general public.

The Atlas is based upon various Genome Projects, and the scientists involved in its creation were pathologists, developmental and molecular biologists as well as geneticists from 14 research groups from non-university institutions, universities and six university clinics.

Project coordinator, Professor Thomas Willnow (MDC), has said that the Kidney Atlas will also be of great significance for the research of metabolic disorders, which lead to kidney damage such as diabetes.

The Kidney Atlas was presented at MDC during a two-day symposium, which was attended by approximately 100 researchers. (ANI)

For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more